Breaking News: Bullish on American Premium Water (OTC:HIPH) as FDA Hearings Have CBD Coming to a Store Near You
New York, NY -- June 3, 2019 -- InvestorsHub NewsWire -- via www.cannabishempwire.com; Cannabis Hempwire News Commentary -- With recent hearings from the FDA on setting guidelines for consumption of cannabidiol (CBD), it’s a matter of when not if when CBD will be available at every store around the corner. American Premium Water Corporation (OTC: HIPH) is a Company in the CBD space that is undervalued. Today they announced that they would be retiring 30million shares to treasury, something that is unheard of in the OTC space. HIPH recently entered into a financing agreement with an institutional investor at a $0.40 valuation, over ten times the current market valuation. The Company is focused on leveraging its proprietary Hydro Nano technology that delivers CBD particles to the bloodstream with over 90% higher bioavailability compared to regular CBD infused beverages. Last month HIPH provided guidance on projected revenue for 2019 of $1 million when they received a two container order from a distributer in the UK. Canaccord’s Bobby Burleson and Jonathan DeCourcey claimed that the drinks could be poised to outpace general demand for marijuana products by over two times, capturing 20% of the market for cannabis edibles by 2022. HIPH currently priced below $0.03 is a great buying opportunity.
Other companies such CV Sciences, Inc. (OTC: CVSI), a hemp life science company is poised to benefit from the FDA hearings. The company focuses on developing and commercializing prescription drugs utilizing synthetic cannabidiol (CBD) as the active pharmaceutical ingredient. Its initial drug candidate, CVSI-007, combines CBD and nicotine for the treatment of smokeless tobacco use and addiction. The company also engages in the development, manufacture, marketing, and sale of consumer products containing plant-based CBD under the PlusCBD Oil name in various market sectors, including nutraceutical, beauty care, specialty foods, and vape.
Other CBD beverage companies, such as Puration, Inc (OTC:PURA), was one of the first to develop CBD-infused beverages, launching its EVERx CBD Infused Sports Waters in the spring of 2017. Since then, they have been expanding distribution and brand awareness for the product, forging a relationship with the Arnold Sports Festival, appearing at events worldwide for the past few years. The Company has grown revenues to over $1million, and recently announced guidance of $4million for 2019.
Kona Gold Solutions, Inc. (OTC: KGKG), is another hemp and CBD company that is poised to grow after FDA hearings, partnering with sixteen new distributors within the last thirty days. These new distribution partners are located in California, Idaho, Indiana, Kentucky, Louisiana, Minnesota, Nevada, New Mexico, New York, Oklahoma, Texas, Virginia, Washington, and Wisconsin. With its Kona Gold Hemp Energy Drinks and HighDrate CBD Energy Waters, the Company continues to grow its market share in the hemp and CBD infused beverage sector by adding new distribution partners, further solidifying itself as a leader in its market. Kona Gold currently has distribution partners in 24 states.
With the FDA poised to fully embrace CBD, the market is expanding exponentially, many investors are flocking to the cannabis market. There are many players in the space, but with tremendous growth still to come as mainstream outlets become distributors, we believe that American Premium Water Corporation, CV Sciences, Inc., Puration, Inc, and Kona Gold Solutions, Inc. have the potential to grow fast with the market.
To read the rest of the article go to https://cannabishempwire.com/commentary/f/breaking-news-fda-hearings-have-cbd-coming-to-a-store-near-you
CannabisHempWire.com (CHW )is a third party publisher and news dissemination service provider. CHW is NOT affiliated in any manner with any company mentioned herein. CHW is news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. CHW's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release or opinion of the writer. CHW is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. CHW has not been compensated for this release and HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur.